查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1401987

到 2030 年血管成形术球囊的全球市场预测：按类型、材料、适应症、最终用户和地区进行分析

Angioplasty Balloons Market Forecasts to 2030 - Global Analysis By Type (Drug Eluting Balloons, Normal Balloons, Cutting Balloons, Scoring Balloons and Other Types), Material, Indication, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3个工作天内

价格

根据 Stratistics MRC 的数据，2023 年全球血管成形球囊市场规模将达到 25 亿美元，预计到 2030 年将达到 37 亿美元，预测期内复合年增长率为 5.9%。

血管成形术球囊市场主要是由周边动脉疾病和冠状动脉疾病等心血管疾病的日益普及所推动的。这些球囊在治疗动脉阻塞时必不可少，且血管成形术球囊的安全性和有效性已显着提高，包括药物涂层球囊（DCB）、球囊导管和更好材料的使用，透过该领域的不断发展而提高。

根据2023 年2 月发表的《美国心臟病学会杂誌》，动脉粥状硬化性心血管疾病的发生率对于10 年预测风险高的人来说，每1,000 人年的发生率为2.60；对于低风险但30 年预测风险高的人来说，每1,000 人年动脉粥状硬化性心血管疾病的发生率为1.87。年预测风险为 0.32，10 年和 30 年预测风险较低的为 0.32。

心血管疾病盛行率增加

随着全球心血管疾病发生率的增加，对血管成形术等手术的需求也不断改变。这些治疗的关键是血管成形术球囊，用于疏通狭窄或闭塞的动脉并恢復血流。由于医疗机构和供应商需要更多的血管成形球囊来满足患者的需求，因此预计市场将随着对血管成形术治疗的需求不断增长而发展。

高成本

对于患者来说，接受先进或客製化的球囊血管成形术可能成本高昂。经济弱势或保险不足地区的患者可能会面临获得这些服务的障碍，这可能会影响市场渗透率。如果患者和医疗保健相关人员选择更实惠的选择或传统的球囊血管成形术而不是更先进和昂贵的球囊血管成形术，经济问题可能会导致市场分裂。

快速引进尖端技术

先进技术的快速引进刺激了血管成形术球囊设计和製造的创新。公司有奖励花钱进行研发，生产更复杂、更有用的气球，包括药物涂层气球、刮伤气球以及具有专有材料和涂层的气球。成功开发并将最尖端科技融入血管成形术球囊的公司面临竞争。透过提供满足行业未满足需求的创意解决方案，这些公司可能会占领更大的市场占有率。

与血管成形术相关的併发症

与血管成形术相关的血栓症、夹层和动脉损伤的风险可能使医疗相关人员对使用血管成形术球囊信心不足。这可能会导致采取更加谨慎的方法或降低这些设备的采用率。此外，复杂的案例可能会导致监管监督的加强或更彻底的评估，这可能会延迟新的血管成形球囊技术的核准过程。

COVID-19 的影响

在大流行的早期阶段，世界各地的许多医院和医疗机构推迟了选择性手术，包括非紧急血管成形术。这是为了保护资源、减少患者接触病毒并优先考虑 COVID-19 患者。这导致患者去医院和诊所的频率降低，而对感染的恐惧导致心血管疾病诊断和血管成形术减少，阻碍了市场成长。

预计药物释放型球囊部分在预测期内将是最大的

由于药物释放型球囊的主要目的是降低血管再阻塞的发生率（即透过血管成形术治疗的动脉血管再阻塞），因此该细分市场预计将出现良好的增长。透过防止动脉壁细胞增殖，药物涂层减少了动脉再次收缩的机会。药物释放型球囊作为一种可行的治疗选择受到介入性心臟病专家的欢迎和青睐，特别是在支架放置不理想或难以安装支架的小静脉中。

聚氨酯领域预计在预测期内复合年增长率最高

预计聚氨酯领域在预测期内将出现最高的复合年增长率。聚氨酯的弹性和耐用性使其成为需要强度和弹性的医疗设备的合适材料。聚氨酯血管成形球囊可设计为具有可调节的充气和放气特性，从而在治疗过程中实现精确的动脉扩张。由于其独特的材料特性，聚氨酯血管成形术球囊仍然是大型血管成形术设备市场的领先选择。

占有率最大的地区

由于高龄化、不良饮食习惯、肥胖率增加和生活方式的改变，预计亚太地区在预测期内将占据最大的市场占有率。心血管疾病患者数量的增加增加了对血管成形术等介入性心臟病治疗的需求。医疗设备的安全性和有效性由该地区各国的各种法律规范确保。为了在每个国家销售产品，製造商必须遵守某些法规。

复合年增长率最高的地区：

由于介入性心臟病学设备的大幅增加，预计欧洲在预测期内将出现最高的复合年增长率。此外，欧洲心血管疾病的盛行率正在增加，这推动了对这些设备的需求，以及球囊成分、药物涂层球囊和成像技术的不断进步，这将提高血管成形术的有效性和安全性。生物可吸收支架和药物释放型球囊等新创新正在普及并推动市场成长。

免费客製化服务：

订阅此报告的客户可以利用以下免费自订选项之一：

  • 公司简介
    • 其他市场参与企业的综合分析（最多 3 家公司）
    • 主要企业SWOT分析（最多3家企业）
  • 区域分割
    • 根据客户兴趣对主要国家的市场估计/预测/复合年增长率（註：基于可行性检查）
  • 竞争基准化分析
    • 根据产品系列、地理分布和策略联盟对主要企业基准化分析

目录

第一章执行摘要

第二章 前言

  • 概述
  • 相关利益者
  • 调查范围
  • 调查方法
    • 资料探勘
    • 资料分析
    • 资料检验
    • 研究途径
  • 研究资讯来源
    • 主要研究资讯来源
    • 二次研究资讯来源
    • 先决条件

第三章市场趋势分析

  • 介绍
  • 促进因素
  • 抑制因素
  • 机会
  • 威胁
  • 最终用户分析
  • 新兴市场
  • 新型冠状病毒感染疾病（COVID-19）的影响

第4章波特五力分析

  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新进入者的威胁
  • 竞争公司之间的敌对关係

第五章全球血管成形术球囊市场：依类型

  • 介绍
  • 药物释放型球囊
  • 一般气球
  • 切割球囊
  • 球囊导管
  • 其他类型

第六章全球血管成形术球囊市场：依材料分类

  • 介绍
  • 聚氨酯
  • 硅胶胺甲酸乙酯共聚物
  • 尼龙
  • 其他材料

第七章全球血管成形术球囊市场：依适应症分类

  • 介绍
  • 血管新生
  • 肾动脉血管成形术
  • 末稍血管
  • 颈动脉血管成形术
  • 静脉血管成形术
  • 冠状动脉血管成形术
  • 其他适应症

第八章全球血管成形术球囊市场：依最终用户分类

  • 介绍
  • 门诊手术中心
  • 医院
  • 导管实验室
  • 专科诊所
  • 诊断中心
  • 其他最终用户

第九章全球血管成形术球囊市场：按地区

  • 介绍
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 义大利
    • 法国
    • 西班牙
    • 欧洲其他地区
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 纽西兰
    • 韩国
    • 其他亚太地区
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地区
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 卡达
    • 南非
    • 中东和非洲其他地区

第10章 主要进展

  • 合约、伙伴关係、协作和合资企业
  • 收购和合併
  • 新产品发布
  • 业务扩展
  • 其他关键策略

第十一章 公司简介

  • Boston Scientific Corporation
  • Medtronic
  • Johnson & Johnson Services, Inc.
  • Abbott
  • Cardinal Health
  • Terumo Medical Corporation
  • B. Braun Melsungen AG
  • ENDOCOR GmbH
  • BIOTRONIK
  • Cook
  • Spectranetics
  • CR Bard, Inc.
  • AngioDynamics
  • Becton Dickinson
  • Biomerics
  • INFINITY Angioplasty Balloon
  • MicroPort Scientific Corporation
  • Nipro Medical Corporation.
  • Hexacath
  • CTK biotech, Inc
Product Code: SMRC24507

According to Stratistics MRC, the Global Angioplasty Balloons Market is accounted for $2.5 billion in 2023 and is expected to reach $3.7 billion by 2030 growing at a CAGR of 5.9% during the forecast period. The angioplasty balloons market has been driven in large part by the increasing prevalence of cardiovascular illnesses, including peripheral artery disease and coronary artery disease. When treating artery blockages, these balloons are essential and the safety and effectiveness of angioplasty balloons have been improved by ongoing developments in the field, including the use of drug-coated balloons (DCB), scoring balloons, and better materials.

According to the Journal of the American College of Cardiology published in February 2023, the incidence rate of atherosclerotic cardiovascular disease per 1,000 person-years was 2.60 among those with raised 10-year predicted risk, 1.87 in those with low 10-year but elevated 30-year predicted risk and 0.32 in those with low 10-year and 30-year predicted risk.

Market Dynamics:

Driver:

Increasing prevalence of cardiovascular diseases

The necessity for procedures such as angioplasty develops in tandem with the global growth in the incidence of cardiovascular illnesses. An essential part of these treatments are angioplasty balloons, which are used to unblock constricted or obstructed arteries and restore blood flow. Because more angioplasty balloons are needed by healthcare institutions and providers to meet patient demands, the market is expected to develop as a result of the growing demand for angioplasty treatments.

Restraint:

High cost

Exorbitant expenses may restrict patients' access to sophisticated or customized balloon angioplasty treatments. Market penetration may be impacted by obstacles that patients in areas with little financial resources or insufficient insurance coverage may have when trying to access these services. Problems with affordability might result in market segmentation, when patients or medical professionals choose more affordable options or conventional balloon angioplasty techniques over more advanced, costly ones.

Opportunity:

Quick adoption of advanced technologies

Innovation in angioplasty balloon design and production is stimulated by the rapid adoption of sophisticated technology. In order to produce more sophisticated and useful balloons, such as those with coatings that are drug-coated, scored, or made of unique materials and coatings, it incentivizes businesses to spend money on research and development. Businesses with a competitive edge are those who develop and successfully incorporate cutting-edge technologies into their angioplasty balloons. By providing creative solutions that meet unmet demands in the industry, these businesses would be able to take a bigger chunk of the market

Threat:

Complications associated with angioplasty

The risks of thrombosis, dissection, or artery damage related to angioplasty operations may cause medical professionals to become less confident in their use of angioplasty balloons. This might result in a more circumspect approach or lower rates of these gadgets being adopted. Moreover, complicated cases may be subject to more stringent regulatory monitoring or carry out more thorough assessments, which could cause the clearance process for novel angioplasty balloon technology to lag.

COVID-19 Impact

Many hospitals and healthcare facilities around the world delayed elective operations, including non-urgent angioplasty procedures, during the early stages of the pandemic. In order to protect resources, reduce patient exposure to the virus, and provide priority to COVID-19 patients, this was done. Patients visited hospitals and clinics less frequently because to lockdown procedures and fear of infection, which decreased the amount of cardiovascular disease diagnoses and angioplasty procedures that followed thus hampered the growth of the market.

The drug eluting balloons segment is expected to be the largest during the forecast period

The drug eluting balloons segment is estimated to have a lucrative growth, because using drug-eluting balloons is primarily intended to decrease the incidence of restenosis, which is the re-narrowing of the angioplasty-treated artery. The medication coating lessens the chance that the artery may constrict again by preventing the proliferation of cells in the arterial wall. Drug-eluting balloons have become popular and well-liked by interventional cardiologists as a viable therapeutic option, particularly in situations where stent placement may not be optimal or in narrow veins where stent deployment may be difficult.

The polyurethane segment is expected to have the highest CAGR during the forecast period

The polyurethane segment is anticipated to witness the highest CAGR growth during the forecast period, because of its elasticity and durability, polyurethane is a good material to employ in medical devices that need to be strong and flexible. Polyurethane angioplasty balloons can be designed with regulated inflation and deflation characteristics, enabling accurate artery dilatation throughout the treatment. With their unique material qualities, polyurethane angioplasty balloons remain a viable option within the larger angioplasty devices market.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period owing to the aging population, poor diets, increased obesity rates, and changes in lifestyle in the Asia Pacific region. The number of CVD cases has increased, which has raised demand for interventional cardiology treatments like angioplasty. The safety and effectiveness of medical devices are guaranteed by the various regulatory frameworks that each nation in the area has for them. In order to market their products in their different countries, manufacturers must adhere to certain restrictions.

Region with highest CAGR:

Europe is projected to have the highest CAGR over the forecast period; owing to the considerable increasing interventional cardiology equipment. Moreover, Europe was seeing an increase in the prevalence of cardiovascular disorders, which was driving demand for these devices and the constant progress in balloon composition, drug-coated balloons, and imaging technology was improving angioplasty operations' efficacy and safety. Novelties like bioresorbable scaffolds and drug-eluting balloons were becoming more popular which drives the growth of the market.

Key players in the market:

Some of the key players profiled in the Angioplasty Balloons Market include Boston Scientific Corporation, Medtronic, Johnson & Johnson Services, Inc., Abbott, Cardinal Health, Terumo Medical Corporation, B. Braun Melsungen AG, ENDOCOR GmbH, BIOTRONIK, Cook, Spectranetics, C. R. Bard, Inc., AngioDynamics, Becton Dickinson, Biomerics, INFINITY Angioplasty Balloon, MicroPort Scientific Corporation, Nipro Medical Corporation., Hexacath and CTK biotech, Inc

Key Developments:

In November 2023, Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Relievant Medsystems Inc., a company that offers the only U.S. Food and Drug Administration-cleared Intracept

In November 2023, Medtronic announces FDA approval of minimally invasive device to treat hypertension. Approval is the culmination of ten years of clinical research and development of the Medtronic renal denervation technology

In September 2023, Boston Scientific Announces FDA Approval for the Latest-Generation WATCHMAN FLX™ Pro Left Atrial Appendage Closure Device. The WATCHMAN FLX Pro device is built upon the proven safety and procedural performance

Types Covered:

  • Drug Eluting Balloons
  • Normal Balloons
  • Cutting Balloons
  • Scoring Balloons
  • Other Types

Materials Covered:

  • Polyurethane
  • Silicone Urethane Co-Polymers
  • Nylon
  • Other Materials

Indications Covered:

  • Angioplasty
  • Renal Artery Angioplasty
  • Peripheral Angioplasty
  • Carotid Angioplasty
  • Venous Angioplasty
  • Coronary Angioplasty
  • Other Indications

End Users Covered:

  • Ambulatory Surgical Centers
  • Hospitals
  • Cath Labs
  • Specialty Clinics
  • Diagnostic Centers
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Angioplasty Balloons Market, By Type

  • 5.1 Introduction
  • 5.2 Drug Eluting Balloons
  • 5.3 Normal Balloons
  • 5.4 Cutting Balloons
  • 5.5 Scoring Balloons
  • 5.6 Other Types

6 Global Angioplasty Balloons Market, By Material

  • 6.1 Introduction
  • 6.2 Polyurethane
  • 6.3 Silicone Urethane Co-Polymers
  • 6.4 Nylon
  • 6.5 Other Materials

7 Global Angioplasty Balloons Market, By Indication

  • 7.1 Introduction
  • 7.2 Angioplasty
  • 7.3 Renal Artery Angioplasty
  • 7.4 Peripheral Angioplasty
  • 7.5 Carotid Angioplasty
  • 7.6 Venous Angioplasty
  • 7.7 Coronary Angioplasty
  • 7.8 Other Indications

8 Global Angioplasty Balloons Market, By End User

  • 8.1 Introduction
  • 8.2 Ambulatory Surgical Centers
  • 8.3 Hospitals
  • 8.4 Cath Labs
  • 8.5 Specialty Clinics
  • 8.6 Diagnostic Centers
  • 8.7 Other End Users

9 Global Angioplasty Balloons Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Boston Scientific Corporation
  • 11.2 Medtronic
  • 11.3 Johnson & Johnson Services, Inc.
  • 11.4 Abbott
  • 11.5 Cardinal Health
  • 11.6 Terumo Medical Corporation
  • 11.7 B. Braun Melsungen AG
  • 11.8 ENDOCOR GmbH
  • 11.9 BIOTRONIK
  • 11.10 Cook
  • 11.11 Spectranetics
  • 11.12 C. R. Bard, Inc.
  • 11.13 AngioDynamics
  • 11.14 Becton Dickinson
  • 11.15 Biomerics
  • 11.16 INFINITY Angioplasty Balloon
  • 11.17 MicroPort Scientific Corporation
  • 11.18 Nipro Medical Corporation.
  • 11.19 Hexacath
  • 11.20 CTK biotech, Inc

List of Tables

  • Table 1 Global Angioplasty Balloons Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Angioplasty Balloons Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Angioplasty Balloons Market Outlook, By Drug Eluting Balloons (2021-2030) ($MN)
  • Table 4 Global Angioplasty Balloons Market Outlook, By Normal Balloons (2021-2030) ($MN)
  • Table 5 Global Angioplasty Balloons Market Outlook, By Cutting Balloons (2021-2030) ($MN)
  • Table 6 Global Angioplasty Balloons Market Outlook, By Scoring Balloons (2021-2030) ($MN)
  • Table 7 Global Angioplasty Balloons Market Outlook, By Other Types (2021-2030) ($MN)
  • Table 8 Global Angioplasty Balloons Market Outlook, By Material (2021-2030) ($MN)
  • Table 9 Global Angioplasty Balloons Market Outlook, By Polyurethane (2021-2030) ($MN)
  • Table 10 Global Angioplasty Balloons Market Outlook, By Silicone Urethane Co-Polymers (2021-2030) ($MN)
  • Table 11 Global Angioplasty Balloons Market Outlook, By Nylon (2021-2030) ($MN)
  • Table 12 Global Angioplasty Balloons Market Outlook, By Other Materials (2021-2030) ($MN)
  • Table 13 Global Angioplasty Balloons Market Outlook, By Indication (2021-2030) ($MN)
  • Table 14 Global Angioplasty Balloons Market Outlook, By Angioplasty (2021-2030) ($MN)
  • Table 15 Global Angioplasty Balloons Market Outlook, By Renal Artery Angioplasty (2021-2030) ($MN)
  • Table 16 Global Angioplasty Balloons Market Outlook, By Peripheral Angioplasty (2021-2030) ($MN)
  • Table 17 Global Angioplasty Balloons Market Outlook, By Carotid Angioplasty (2021-2030) ($MN)
  • Table 18 Global Angioplasty Balloons Market Outlook, By Venous Angioplasty (2021-2030) ($MN)
  • Table 19 Global Angioplasty Balloons Market Outlook, By Coronary Angioplasty (2021-2030) ($MN)
  • Table 20 Global Angioplasty Balloons Market Outlook, By Other Indications (2021-2030) ($MN)
  • Table 21 Global Angioplasty Balloons Market Outlook, By End User (2021-2030) ($MN)
  • Table 22 Global Angioplasty Balloons Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 23 Global Angioplasty Balloons Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 24 Global Angioplasty Balloons Market Outlook, By Cath Labs (2021-2030) ($MN)
  • Table 25 Global Angioplasty Balloons Market Outlook, By Specialty Clinics (2021-2030) ($MN)
  • Table 26 Global Angioplasty Balloons Market Outlook, By Diagnostic Centers (2021-2030) ($MN)
  • Table 27 Global Angioplasty Balloons Market Outlook, By Other End Users (2021-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.